| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | Mar 19, 2019 | GT Biopharma, Inc. | CEO | Sell | 27.5 | -176,980 | -11.58% | ✗ | $177 |
| Aug 10, 2017 | Aug 11, 2017 | MANNKIND CORP | Corp VP, CMO | Sell | 27.5 | -296 | -9.19% | ✗ | $340.4 |